Delivery Order SPE2DR25D1017-SPE2DR26F9ANY
- Not listed
- The Defense Logistics Agency awarded a $5,771.92 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete openly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a ceiling value of $10,727.51 and an ultimate completion date of November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,633.25 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract utilizes a firm fixed price arrangement with an ultimate completion date of August 8, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $35,750.42 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitive award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,833.28 on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion scheduled for October 28, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) vials valued at $6,821.38. This non-competitive, firm fixed-price delivery order is due for completion by December 12, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, supporting federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,797.50 for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of August 21, 2025. This competitive award, issued on August 20, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,491.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials. This is a non-set-aside competitive award with a completion date of November 25, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $6,644.70 and an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $5,689.24 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 16, 2025, and performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9ANYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,604.70 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 2, 2025, and performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger federal pharmaceutical supply relationship with the federal government. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver a broad range of medications and medical supplies to support military healthcare programs. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive award processes and maintains a substantial portfolio of delivery orders for specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/30/25 |